Clinical Trial Update: A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) [Phase 3]

View source ↗

Summary

Phase 3 study LP352 for Developmental and Epileptic Encephalopathy is currently enrolling by invitation in children and adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy

Drugs mentioned

• LP352

Snippet

Sponsor: Longboard Pharmaceuticals | Conditions: Developmental and Epileptic Encephalopathy | Phase 3 | Status: ENROLLING_BY_INVITATION